Key result
Updated Universal Definition reframes heart failure diagnosis in CKD around longitudinal symptoms over rigid LVEF.
Why the study?
Heart failure and chronic kidney disease are biologically entwined and clinically difficult to disentangle, requiring reconsideration under the 2026 Second Universal Definition of Heart Failure.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The new framework moves beyond rigid ejection fraction thresholds, recognizes at-risk and pre-heart failure stages, and tracks trajectories such as worsening versus decompensation. The authors point out that in kidney disease, dyspnea, edema, raised biomarkers, and structural cardiac changes are common but individually non-diagnostic, especially in dialysis. And they caution against diagnostic inflation while welcoming a shared vocabulary for cardiac and kidney teams.”
The application of the 2026 Second Universal Definition of Heart Failure to CKD offers a standardized vocabulary to distinguish reversible congestion from chronic cardiac disease and improve shared decision-making.
BACKGROUND: Heart failure and chronic kidney disease (CKD) are biologically entwined and clinically difficult to disentangle. The 2026 Second Universal Definition of Heart Failure reframes heart failure as a syndrome defined by symptoms and signs, objective evidence of structural or functional cardiac abnormality, and a dynamic disease trajectory. Its implications for CKD and dialysis require focused consideration. SCOPE: This review interprets the consensus in a nephrology context. It considers the move beyond rigid left ventricular ejection fraction (LVEF) thresholds; the recognition of at-risk and pre-heart-failure stages; causal classification; trajectories of improvement, remission, recovery, worsening, and decompensation; and the effects of social and geographic context. KEY OBSERVATIONS: In CKD, dyspnoea, oedema, biomarker elevation, and cardiac structural abnormalities are frequent but individually non-diagnostic. Diagnosis requires integration of longitudinal symptoms, congestion, imaging, biomarkers, volume status, and response to treatment. The new framework is especially pertinent to dialysis, where fluid shifts, access flow, myocardial stunning, and altered biomarker clearance complicate phenotyping. It also supports earlier prevention, careful distinction between worsening and decompensated heart failure, and aetiology-directed evaluation rather than reliance on LVEF or administrative hospitalisation codes. INTERPRETATION: The consensus offers nephrology a coherent vocabulary. Its value will depend on avoiding diagnostic inflation, standardising heart-failure phenotyping in CKD trials, and integrating cardiac and kidney care before recurrent congestion and kidney failure occur. It should also improve shared decision making by separating potentially reversible congestion from chronic cardiac disease, and by defining realistic therapeutic aims: prevention, symptom relief, fewer decompensations, preservation of function, and longer survival.
No takes yet. Share an insight, caveat, or question.
Zoccali et al. (2026) conducted a review in Heart failure and chronic kidney disease. Second Universal Definition of Heart Failure was evaluated. The 2026 Second Universal Definition of Heart Failure offers a new diagnostic framework for patients with chronic kidney disease, emphasizing longitudinal symptom integration over rigid LVEF thresholds.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: